The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Early discontinuation of tamoxifen: A Lesson for oncologists
Open accessAbstract
BACKGROUND.: Five years of treatment provides the optimum duration of tamoxifen therapy for the prevention of breast cancer recurrence and mortality. Durations of adjuvant tamoxifen therapy less than 5 years are associated with poorer outcomes for breast cancer patients. The purpose of the study was to assess rates of tamoxifen nonpersistence (early discontinuation) in women aged 35 years or older using prescription refill data from a national prescribing database. METHODS.: A cohort of 2816 women commencing tamoxifen as initial hormonal therapy was identified between January 2001 and January 2004. The cumulative tamoxifen persistence rate was calculated for these women and the relation between nonpersistence and clinical and demographic variables assessed. RESULTS.: Within 1 year of commencing treatment the cumulative tamoxifen nonpersistence rate was 22.1%. This is twice the rate of treatment discontinuation observed in other studies by this time. By the end of follow‐up at 3.5 years, the cumulative nonpersistence rate had increased to 35.2%. Determinants of nonpersistence identified included age and a history of antidepressant use. CONCLUSIONS.: The rate of nonpersistence with tamoxifen therapy is higher than previously reported. This study demonstrates that persistence with tamoxifen cannot be assumed and raises concerns about persistence with other oral hormonal therapies for breast cancer and oral antineoplastics in general. Oncologists need to identify those at risk of nonpersistence and develop strategies to combat this barrier to treatment success. Cancer 2007. © 2007 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.14.2101 · Cited by 4,177
Tamoxifen for early breast cancer: an overview of the randomised trials
(1998) · The Lancet · doi:10.1016/s0140-6736(97)11423-4 · Cited by 4,085
Focan, C., Steinberg, S. M., Blichert-Toft, M., Forbes, J., Collins, R. D., Anderson, S., Margreiter, R., Harwood, C. S., Andersen, K., Beighton, G., et al. (1998) · PubMed · Cited by 2,146
Methods for evaluation of medication adherence and persistence using automated databases
Andrade, S. E., Kahler, K. H., Frech, F., & Chan, K. A. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1230 · Cited by 1,079
Fisher, B., Dignam, J., Wolmark, N., Wickerham, D. L., Fisher, E. R., Mamounas, E., Smith, R., Begovic, M., Dimitrov, N. V., Margolese, R. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05036-9 · Cited by 1,040
Fisher, B., Dignam, J., Bryant, J., DeCillis, A., Wickerham, D. L., Wolmark, N., Costantino, J., Redmond, C., Fisher, E. R., Bowman, D. M., et al. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.21.1529 · Cited by 861
Loprinzi, C. L., Kugler, J. W., Sloan, J. A., Mailliard, J. A., LaVasseur, B. I., Barton, D. L., Novotny, P. J., Dakhil, S. R., Rodger, K., Rummans, T. A., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03403-6 · Cited by 737
Influence of psychological response on survival in breast cancer: a population-based cohort study
Watson, M., Haviland, J., Greer, S., Davidson, J., & Bliss, J. (1999) · The Lancet · doi:10.1016/s0140-6736(98)11392-2 · Cited by 705
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
Partridge, A. H., Wang, P. S., Winer, E. P., & Avorn, J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.071 · Cited by 676
Fisher, B., Bryant, J., Dignam, J. J., Wickerham, D. L., Mamounas, E. P., Fisher, E. R., Margolese, R. G., Nesbitt, L., Paik, S., Pisansky, T. M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.101 · Cited by 667
Fyles, A. W., McCready, D. R., Manchul, L. A., Trudeau, M. E., Merante, P., Pintilie, M., Weir, L. M., & Olivotto, I. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040595 · Cited by 651
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
Interventions for enhancing medication adherence
Haynes, R., Yao, X., Degani, A., Kripalani, S., Garg, A., & McDonald, H. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub2 · Cited by 517
Granger, B. B., Swedberg, K., Ekman, I., Granger, C. B., Olofsson, B., McMurray, J. J., Yusuf, S., Michelson, E. L., & Pfeffer, M. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67760-4 · Cited by 478
Andrade, S. E., Walker, A. M., Gottlieb, L. K., Hollenberg, N. K., Testa, M. A., Saperia, G. M., & Platt, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321703 · Cited by 379
Predictors of medication adherence in the elderly
Balkrishnan, R. (1998) · Clinical Therapeutics · doi:10.1016/s0149-2918(98)80139-2 · Cited by 375
Adherence to tamoxifen over the five-year course
Lash, T. L., Fox, M. P., Westrup, J. L., Fink, A. K., & Silliman, R. A. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9193-0 · Cited by 320
Waterhouse, D. M., Calzone, K. A., Mele, C., & Brenner, D. E. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.6.1189 · Cited by 313
Intentional and non-intentional non-adherence to medication amongst breast cancer patients
Atkins, L., & Fallowfield, L. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.03.004 · Cited by 300
Adjuvant Tamoxifen: Predictors of Use, Side Effects, and Discontinuation in Older Women
Demissie, S., Silliman, R. A., & Lash, T. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.322 · Cited by 300
Fink, A. K., Gurwitz, J., Rakowski, W., Guadagnoli, E., & Silliman, R. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.064 · Cited by 281
Fisher, B., Anderson, S., Tan-Chiu, E., Wolmark, N., Wickerham, D. L., Fisher, E. R., Dimitrov, N. V., Atkins, J. N., Abramson, N., Merajver, S., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.931 · Cited by 272
Watson, M., Homewood, J., Haviland, J., & Bliss, J. M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.01.012 · Cited by 256
Adherence beliefs among breast cancer patients taking tamoxifen
Grunfeld, E. A., Hunter, M. S., Sikka, P., & Mittal, S. (2005) · Patient Education and Counseling · doi:10.1016/j.pec.2004.10.005 · Cited by 245
Effect of Depression on Diagnosis, Treatment, and Survival of Older Women with Breast Cancer
Goodwin, J. S., Zhang, D. D., & Ostir, G. V. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52018.x · Cited by 234
Depression as a Prognostic Factor for Breast Cancer Mortality
Hjerl, K., Andersen, E. W., Keiding, N., Mouridsen, H. T., Mortensen, P. B., & Jørgensen, T. (2003) · Psychosomatics · doi:10.1176/appi.psy.44.1.24 · Cited by 223
Dailey, G., Kim, M. S., & Lian, J. F. (2001) · Clinical Therapeutics · doi:10.1016/s0149-2918(01)80110-7 · Cited by 176
Fallowfield, L., Atkins, L., Catt, S., Cox, A., Coxon, C., Langridge, C., Morris, R., & Price, M. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj044 · Cited by 173
Adjustment to breast cancer: age‐related differences in coping and emotional distress
Compas, B. E., Stoll, M. F., Thomsen, A. H., Oppedisano, G., Epping‐Jordan, J. E., & Krag, D. N. (1999) · Breast Cancer Research and Treatment · doi:10.1023/a:1006164928474 · Cited by 167
Kimmick, G. G., Lovato, J., McQuellon, R., Robinson, E., & Muss, H. B. (2006) · The Breast Journal · doi:10.1111/j.1075-122x.2006.00218.x · Cited by 160
Long-term persistence with antihypertensive drugs in new patients
Esposti, E. D., Sturani, A., Martino, M. D., Falasca, P., Novi, M. V., Baio, G., Buda, S., & Volpe, M. (2002) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001418 · Cited by 156
The Psychosocial Impact of Cancer on the Elderly: A Comparison with Younger Patients
Ganz, P. A., Schag, C. C., & Heinrich, R. L. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb07154.x · Cited by 116
Wang, P. S., Benner, J. S., Glynn, R. J., Winkelmayer, W. C., Mogun, H., & Avorn, J. (2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.819 · Cited by 113
Adjuvant Tamoxifen Prescription in Women 65 Years and Older With Primary Breast Cancer
Silliman, R. A., Guadagnoli, E., Rakowski, W., Landrum, M. B., Lash, T. L., Wolf, R., Fink, A. K., Ganz, P. A., Gurwitz, J. H., Borbas, C., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.137 · Cited by 92
Pilot evaluation of citalopram for the relief of hot flashes.
Barton, D. L., Loprinzi, C. L., Novotny, P., Shanafelt, T. D., Sloan, J. A., Wahner‐Roedler, D. L., Rummans, T. A., Christensen, B. J., Dakhil, S. R., & Martin, L. (2003) · PubMed · Cited by 91
Perreault, S., Blais, L., Dragomir, A., Bouchard, M.-H., Lalonde, L., Laurier, C., & Collin, J. (2005) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-005-0980-z · Cited by 66
Oncologistsʼ views of cancer patient noncompliance
Hoagland, A. C., Morrow, G. R., Bennett, J. M., et al. (1983) · American Journal of Clinical Oncology · doi:10.1097/00000421-198304000-00018 · Cited by 52
Skeletal scintigraphy in patients with bilateral retinoblastoma
Pratt, C. B., Crom, D. B., Chenaille, P. J., Magill, L., & Meyer, D. (1990) · Cancer · doi:10.1002/1097-0142(19900101)65:1<17::aid-cncr2820650106>3.0.co;2-i · Cited by 13
Hot-flashes in breast cancer survivors: effectiveness of low-dosage fluoxetine. A pilot study.
Mariani, L., Quattrini, M., Atlante, M., Galati, M., Barbati, A., & Giannarelli, D. (2005) · PubMed · Cited by 4
Cited by
Hershman, D. L., Shao, T., Kushi, L. H., Buono, D., Tsai, W. Y., Fehrenbacher, L., Kwan, M., Gomez, S. L., & Neugut, A. I. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1132-4 · Cited by 870
Hershman, D. L., Kushi, L. H., Shao, T., Buono, D., Kershenbaum, A., Tsai, W.-Y., Fehrenbacher, L., Lin Gomez, S., Miles, S., & Neugut, A. I. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9655 · Cited by 828
Burstein, H. J., Prestrud, A. A., Seidenfeld, J., Anderson, H., Buchholz, T. A., Davidson, N. E., Gelmon, K. E., Giordano, S. H., Hudis, C. A., Malin, J., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3756 · Cited by 796
The impact of comorbidity on cancer survival: a review
Sogaard, M., W. Thomsen, R., Bossen, Henrik Toft Sørensen, H., & Nørgaard, M. (2013) · Clinical Epidemiology · doi:10.2147/clep.s47150 · Cited by 603
Patient adherence and persistence with oral anticancer treatment
Ruddy, K., Mayer, E., & Partridge, A. (2009) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20004 · Cited by 569
Metadata
- Authors
- Barron, T. I., Connolly, R., Bennett, K., Feely, J., & Kennedy, M. J.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2007-01-22
- Volume
- 109
- Issue
- 5
- Pages
- 832-839
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1519097020
- Cited by
- 279
- References
- 41
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.